Skip to content

Clinical trials

Phase 2/3 Leukemia, Myeloid, Acute trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2/3 Country / region: United Kingdom Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20141
20151
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Cardiff University1
Janssen Research & Development, LLC1
Taiho Oncology, Inc.1
The University of New South Wales1
University of Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute6
Myelodysplastic Syndromes3
Anemia, Refractory, with Excess of Blasts2
Leukemia2
Congenital Abnormalities1
Hematologic Diseases1
Leukemia, Basophilic, Acute1
Leukemia, Eosinophilic, Acute1
Leukemia, Erythroblastic, Acute1
Leukemia, Megakaryoblastic, Acute1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.